Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings

In this activity, multidisciplinary experts discuss the importance of suspecting and testing for acute hepatic porphyria in patients with indicative clinical symptoms and signs. For the complete activity, including supporting material, please visit: www.peervoice.com/GVP861. Presented by: Miguel Bajouco, MD, MSc, David Cassiman, MD, PhD, Rebecca Karp Leaf, MD, Katherine Pocius, MD, MPH, and Paulo Lima Serrano, MD, PhD. Learning Objectives: Recognise the importance of early suspicion of acute hepatic porphyria (AHP) in reducing diagnostic delays and improving outcomes; Explain how to test for AHP in patients with indicative clinical symptoms and signs; and Analyse presenting symptoms and clinical history to determine when AHP should be strongly suspected and diagnostic testing initiated.